Followup results of a combination of calcitonin gene-related peptide and prostaglandin E1 in the treatment of erectile dysfunction

Journal of Urology

Volumn 149, Issue 5 SUPPL., 1993, Pages 1296-1298

  Djamilian, M ^a   Stief, C G ^a   Kuczyk, M ^a   Jonas, U ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

calcitonin gene related peptide; impotence; penile erection; prostaglandins E

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; PAPAVERINE; PHENTOLAMINE; PROSTAGLANDIN E1;

ARTICLE; COMBINATION CHEMOTHERAPY; DRUG EFFICACY; DRUG POTENTIATION; HUMAN; HUMAN TISSUE; IMPOTENCE; INJECTION PAIN; MAJOR CLINICAL STUDY; MALE; MALE SEXUAL DYSFUNCTION; PENIS ERECTION; PEYRONIE DISEASE; PRIORITY JOURNAL;

EID: 0027266895     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(17)36372-3     Document Type: Article

References (30)

1. S.E. Mayer Neurohumural transmission and the autonomic nervous system chapt. 4 A.G. Gilman A. Goodman L.S. Gilman The Pharmacological Basis of Therapeutics vol. 7 1985 Macmillan Publishing Co. New York 56 90
2. B. von Anrep N. Cybulsky Zur Physiologie der gefässerweiternden und gefässverengernden Nerven Med. Wchschr 20 1884 215
3. C. Stief F. Benard R. Bosch S. Aboseif L. Nunes T.F. Lue E.A. Tanagho Acetylcholine as a possible neurotransmitter in penile erection J. Urol 141 1989 1444
4. H.J. Kirkeby J.C. Jprgensen B. Ottensen Neuropeptide Y (NPY) in human penile corpus cavernosum tissue and circumflex veins—occurrence and in vitro effects J. Urol. 145 1991 605
5. T.C. Gerstenberg P. Metz B. Ottensen J. Fahrenkrug Intracavernous self-injection of vasoactive intestinal polypeptide and phentolamine in the management of erectile failure J. Urol. 147 1992 1277
6. F. Benard C. Stief R. Bosch S. Aboseif T. Lue E. Tanagho Neuropeptide Y: in vivo study of its effects on erection J. Urol. 141 part 2 1989 185A abstract 63
7. C.G. Stief F. Benard R.J.L.H. Bosch S.R. Aboseif T.F. Lue E.A. Tanagho A possible role for calcitonin-gene-related peptide in the regulation of the smooth muscle tone of the bladder and penis J. Urol. 143 1990 392
8. L.J. Ignarro P.A. Bush G.M. Buga K.S. Wood J.M. Fukoto J. Rajfer Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle Biochem. Biophys. Res. Comm 170 1990 843
9. F. Holmquist H. Hedlung K.-E. Andersson L-NG-nitro arginine inhibits non-adrenergic, non-cholinergic relaxation of human isolated corpus cavernosum Acta Phys. Scand 141 1991 441
10. N. Kim K.M. Azadzoi I. Goldstein I. Saenz de Tejada A nitric oxide-like factor mediates nonadrenergic-noncholinergic neurogenic relaxation of penile corpus cavernosum smooth muscle J. Clin. Invest. 88 1991 112
11. F. Holmquist H. Hedlung K.-E. Andersson Characterisation of inhibitory neurotransmission in the isolated corpus cavernosum from rabbit and man J. Physiol. 449 1992 295
12. F. Holmquist C.G. Stief U. Jonas K.-E. Andersson Effects of the nitric oxide synthase inhibitor NG-nitro-L-arginine on the erectile response to cavernous nerve stimulation in the rabbit Acta Phys. Scand 143 1991 299
13. K.-P. Jünemann P. Alken Pharmacotherapy of erectile dysfunction: a review Int. J. Impotence Res. 1 1989 71
14. N. Ishii H. Watanabe C. Irisawa Y. Kikuchi Y. Kubota S. Kawamura K. Suzuki R. Chiba M. Tokiwa M. Shirai Intracavernous injection of prostaglandin E1 for the treatment of erectile impotence J. Urol. 141 1989 323
15. W. Stackl R. Hasun M. Marberger Intracavernous injection of prostaglandin E1 in impotent man J. Urol. 140 1988 66
16. R. Virag Intracavernous injection of papaverine for erectile failure. Letter to the Editor Lancet 2 1982 938
17. G.S. Brindley Cavernosal alpha-blockade: a new technique for investigating and treating erectile dysfunction Brit. J. Psychiatry 143 1983 332
18. A.W. Zorgniotti R.S. Lefleur Auto-injection of the corpus cavernosum with a vasoactive drug combination for vasculogenic impotence J. Urol. 133 1985 39
19. M. Abozeid K.-P. Juenemann J.-A. Luo T.F. Lue T.-S.B. Yen E.A. Tanagho Chronic papaverine treatment: the effects of repeated injections on the simian erectile response and penile tissue J. Urol 138 1987 1263
20. S.R. Aboseif J. Breza R.J.L.H. Bosch F. Benard C.G. Stief W. Stackl T.F. Lue E.A. Tanagho Local and systemic effects of chronic intracavernous injection of papaverine, prostaglandin E1 and saline in primates J. Urol. 142 1989 403
21. M. Waldhauser P. Schramek Efficiency and side effects of prostaglandin E1 in the treatment of erectile dysfunction J. Urol. 140 1988 525
22. C.G. Stief U. Wetterauer F. Schaebsdau U. Jonas Calcitonin-gene-related peptide: a possible role in human penile erection and its therapeutical application in impotent patients J. Urol. 146 1991 1010
23. C.G. Stief W. Bähren H. Gall W. Scherb Functional evaluation of penile hemodynamics J. Urol. 139 1988 734
24. C.G. Stief M. Djamilian F. Schaebsdau M.C. Truss R.W. Schlick J.H. Abicht E.P. Allhoff U. Jonas Single potential analysis of cavernous electric activity—a possible diagnosis of autonomic impotence? World J. Urol 8 1990 75
25. M.J. Jevtich Non-invasive vascular and neurologic tests in use for evaluation of angiogenic impotence Int. Angiol 3 1984 225
26. E.J.H. Meuleman B.L.H. Belemans W.H. Doesburg W.N.J.C. van Asten S.H. Skotnicki F.M.J. Debruyne Penile pharmacological duplex ultrasonography: a dose-effect study comparing papaverine, papaverine/phentolamine and prostaglandin E1 J. Urol. 148 1992 63
27. J.U. Schwarzer U. Pickl W. Kropp R. Hartung Schwellkörperautoinjektionstherapie mit Calcitonin Gene Related Peptide Urologe A, suppl 31 1992 A9
28. + channels Nature 344 1990 770
29. D. Thiebaud T. Akatsu T. Yamashita T. Suda T. Noda R.E. Martin A.E. Fletcher T.J. Martin Structure-activity relationships in calcitonin gene-related peptide: cyclic AMP response in a preosteoblast cell line (KS-4) J. Bone Min. Res. 6 1991 1137
30. J. Raud T. Lundeberg G. Brodda-Janson E. Theodorsson P. Hedquist Potent anti-inflammatory action of calcitonin gene-related peptide Biochem. Biophys. Res. Comm. 180 1991 1429